About this trial
Medical marijuana use among adults 50 and older has more than doubled in the past decade with exponential increases projected in this demographic by 2050, and prescription opioids are one of the most common treatments for pain management in this population. To date, no studies systematically assess driving performance in a rigorous and ecologically valid manner accounting for long-term medical marijuana use and/or the combined effect of prescription opioid use in adults 50 and older who endorse chronic or severe non-malignant pain. Further, studies examining how older adults self-regulate prescription medication use and driving behavior is limited, with none rigorously examining medical marijuana.
Eligibility criteria
Qualifiers
Age 50 and older who endorse chronic or severe non-malignant pain
Resident of Florida with an active and valid Florida Drivers License
Can communicate in English
Willing and able to complete study procedures
Disqualifiers
Have active psychosis
Have lost or revoked driving privileges
Score of below the cut 24 (out of 30) on the Montreal Cognitive Assessment (MoCA)
Are a control participant who urine test positive for marijuana use and/or reports any marijuana use in past 10 years
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Florida State University
Lead sponsor
University of Florida
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator